3.1.2 Congenital Melanocytic Nevus

Grading & Level of Importance: B
Review:
2026

W. Burgdorf, Munich; C. Ellis, J. McGrath, London
Revised by G. Girolomoni, Verona; P. Gisondi, Verona; J. Malvehy, Barcelona; M. Maurelli, Verona

ICD-11

 2F20.2

Synonyms

Pigmented birth mark.

Epidemiology

The incidence is 0.2-2.1% in newborns. The incidence in large/giant congenital nevi is 0.005%. M:F= 1:1.17 - 1:1.4.

Definition

Collection of pigmented melanocytes in epidermis and dermis, usually present at birth, often associated with increased numbers of hair follicles.

Read more

Congenital melanocytic nevi (CN) are collection of benign pigmented melanocytes in epidermis and dermis, present at birth, often associated with increased numbers of hair follicles.

Aetiology & Pathogenesis

Embryonal acquired mutation in the tyrosine kinase NRAS (Neuroblastoma RAS) in cells of the neural crest. Rarely, lesions may appear up to 2 years after birth. They are not different from congenital nevi, but sometimes are called tardive congenital nevi.

Signs & Symptoms

Circumscribed brown to black nodules or plaques, often with hypertrichosis. At the very early beginning after birth it may be even a macular lesion which then increase in volume.

Read more

Circumscribed brown to black nodules or plaques, often with hypertrichosis. Small and medium- sized congenital melanocytic nevi are usually round or oval and fairly symmetric.

Localisation

Trunk, head, as well as extremities.

Classification

Estimated size of nevus at birth expected to reach in adulthood:


Type I. Size 1-3 cm: common and harmless, 1:100. 
Type II. Size 3-20 cm: uncommon, 1:1000-1:20000, rarely malignant change. 
Type III. Size >20 cm: usually on the trunk (giant or bathing trunk naevus) 1:500000, risk of melanoma 3-5%.

Read more

Projected adult size (PAS) is the estimated size of nevus at birth expected to reach in adulthood:

PAS 1-3 cm (Small CN): common and risk of melanoma similar to common nevi. Incidence = 1:100.

PAS 3-20 cm (medium CN). Incidence=uncommon, 1:1000-1:20000, rarely malignant change.

PAS >20 cm (large CN)

PAS >40 cm (giant CN)

CN >20 cm usually are on the trunk (i.e. bathing trunk naevus): Incidence = 1:500000; risk of melanoma 3-5%.

In large or giant CN loci of melanin-producing cells within the brain parenchyma, found on magnetic resonance imaging in ∼20% of affected children. Other neurological associations comprise communicating hydrocephalus, arachnoid cysts, syringomyelia, tumors (including astrocytoma, choroid plexus papilloma, ependymoma, and pineal germinoma), and malformations such as Dandy–Walker or Arnold–Chiari. Congenital nevus syndrome is the term that has been introduced for the combination of cutaneous CN and neurological abnormalities.

Laboratory & other workups

Measurement of thickness by ultrasound could be useful.

Dermatopathology

Accumulation of melanocytes at the epidermal-dermal junction and in the dermis, often extending deeply, into the lower reticular dermis, subcutaneous fat and fascia, and even deeper.

Read more

Accumulation of melanocytes at the epidermal-dermal junction and in the dermis, often extending deeply, into the lower reticular dermis, subcutaneous fat and fascia, and even deeper. Helpful is the presence of nevus cells surrounding (cuffing) and within the walls of blood vessels, within adnexal structures such as hair follicles and sweat glands, and within cutaneous nerves, particularly when in the lower half of the reticular dermis.

Course

Permanent, life-long. No tendency to regression.

Read more

Permanent, no tendency to regression. Mean age at diagnosis of melanoma: 15.5 years.

Complications

In giant naevi, risk of leptomeningeal melanosis. Lumbosacral: spina bifida, myelomeningocele. Increased risk of neurological disorders in giant nevi in > 40 cm or those is expected to reach this size in adulthood. In patients with congenital nevi type III, the mean age at diagnosis of developing melanoma is around 15 to 16 years.

Read more

Melanoma. In giant naevi, risk of leptomeningeal melanosis. Lumbosacral: spina bifida, myelomeningocele. Increased risk of neurological disorders in large (>20 cm) and giant nevi in >40 cm or those is expected to reach this size in adulthood.

Diagnosis

Clinical features, histology.

Differential Diagnosis

Haemangioma, dermatofibroma, melanoma, melanocytic nevi, plexiform neurofibromas, see also chapter 3.1.5 Melanocytic nevus.

Read more

Histiocytoma, haemangioma, fibroma, melanoma, plexiform neurofibromas. The differential diagnosis of small congenital nevi includes congenital smooth muscle hamartoma, atypical nevus, melanoma, Becker melanosis.

Prevention & Therapy

Type II and Type III Congenital nevi should have an annual follow-up or whenever parents see significant changes.


Small lesions: none needed, excision if desired.


Medium-sized lesions: consider excision after puberty. 


Large lesions: dermabrasion shortly after birth (does not influence leptomeningeal melanosis), close clinical follow-up and excision of suspicious areas.


The decision to remove a lesion is linked to the risk of melanoma and the cosmetically disfiguring appearance.

Read more

Preventive excision has not shown clinical benefits. The excision is indicated if the congenital nevus exhibits atypical features and melanoma has to be ruled out. For cosmetic reasons the surgical excision of large or congenital nevi is controversial. Excision can be recommended of lesions that are itching, traumatised or in case of verrucous tumours. In large lesions or tumour in visible areas dermabrasion shortly after birth or laser ablation has been suggested as an alternative to surgical excision.

The decision to remove a lesion is linked to the risk of melanoma and the cosmetically disfiguring appearance. However, it is very difficult to remove large or giant congenital nevi completely, and thus the risk of melanoma is reduced but not abolished.

Comments

Be the first one to leave a comment